ACE inhibitors do not induce recombinant human erythropoietin resistance in hemodialysis patients

American Journal of Kidney Diseases

Volumn 35, Issue 6, 2000, Pages 1076-1082

  Abu Alfa, Ali K ^a   Cruz, Dinna ^a   Perazella, Mark A ^a   Mahnensmith, Rex L ^a   Simon, David ^a   Bia, Margaret J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anemia; Angiotensin converting enzyme (ACE) inhibitor; End stage renal disease (ESRD); Erythropoietin; Hemodialysis (HD)

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DISEASE EXACERBATION; DRUG EFFECT; FEMALE; HEMATOCRIT; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE;

EID: 0034042547     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(00)70043-6     Document Type: Article

References (39)

1. AL Kamper OJ Nielsen Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy Scand J Clin Lab Invest 50 1990 611 618
2. BI Shand RR Bailey KL Lynn RA Robson Effect of enalapril on erythrocytosis in hypertensive patients with renal disease Blood Press 4 1995 238 240
3. H Hirakata K Onoyama K Iseki H Kumagai S Fujimi T Omae Worsening of anemia induced by long-term use of captopril in hemodialysis patients Am J Nephrol 4 1984 355 360
4. H Hirakata K Onoyama K Hori M Fujishima Participation of the renin-angiotensin system in the captopril-induced worsening of anemia in chronic hemodialysis patients Clin Nephrol 26 1986 27 32
5. K Onoyama T Sanai K Motomura M Fujishima Worsening of anemia by angiotensin-converting enzyme inhibitors and its prevention by antiestrogenic steroid in chronic hemodialysis patients J Cardiovasc Pharmacol 13 suppl 3 1989 S27 S30
6. A Yoshida K Morozumi T Suganuma J Aoki K Sugito S Nakamura M Ikeda T Oikawa T Fujinami H Kawahara Angiotensin-converting enzyme inhibitor and anemia in a patient undergoing hemodialysis Nephron 59 1991 334 335
7. DV Vlahakos VJ Canzanello MP Madaio NE Madias Enalapril-associated anemia in renal transplant recipients treated for hypertension Am J Kidney Dis 17 1991 199 205
8. M Perazella P McPhedran A Kliger M Lorber E Levy MJ Bia Enalapril treatment of post-transplant erythrocytosis: Efficacy independent of circulating erythropoietin levels Am J Kidney Dis 26 1995 495 500
9. PJ Conlon J Farrell J Donohoe M Carmody JJ Walshe The beneficial effect of enalapril on erythrocytosis after renal transplantation Transplantation 56 1993 217 219
10. GM Danivotch NJ Jamgotchian PH Eggena W Paul JD Barrett A Wilkinson DB Lee Angiotensin-converting enzyme inhibition in the treatment of renal transplant erythrocytosis. Clinical experience and observation of mechanism Transplantation 60 1995 132 137
11. MS Islam B Bourbigot JP Codet B Songy G Fournier J Cledes Captopril induces correction of postrenal transplant erythremia Transpl Int 3 1990 222 225
12. RS Gaston BA Julian CV Barker AG Diethelm JJ Curtis Enalapril: Safe and effective therapy for post-transplant erythrocytosis Transplant Proc 25 1993 1029 1031
13. K Rell K Koziak I Jarzyo M Lao Z Gaciong Correction of post-transplant erythrocytosis with enalapril Transplantation 57 1994 1059 1063
14. L Rostaing C Demur A Hyun D Durand JJ Lloveras JM Suc Erythrocytosis after renal transplant: Study of erythroid progenitors and response to enalapril Transplant Proc 26 1994 280 281
15. LF Morrone S Di Paolo F Logoluso A Schena G Stallone F Giorgino FP Schena Interference of angiotensin-converting enzyme inhibitors on erythropoiesis in kidney transplant recipients: Role of growth factors and cytokines Transplantation 64 1997 913 918
16. M Mazzali GA Filho Use of aminophylline and enalapril in post-transplant polycythemia Transplantation 65 1998 1461 1464
17. DN Cruz MA Perazella AK Abu-Alfa RL Mahnensmith Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance? Am J Kidney Dis 28 1996 535 540
18. PJ Conlon F Albers D Butterly SJ Schwab ACE inhibitors do not affect erythropoietin efficacy in haemodialysis patients Nephrol Dial Transplant 8 1993 1358 (letter)
19. C Charytan A Goldfarg-Rumyantzev YF Wang M Schwenk BS Spinowitz Effect of angiotensin-converting enzyme inhibitors on response to erythropoietin therapy in chronic dialysis patients Am J Nephrol 18 1998 498 503
20. JA Sanchez ACE inhibitors do not decrease rHuEPO response in patients with end-stage renal failure Nephrol Dial Transplant 10 1995 1476 1477
21. M Kubo H Hirakata T Hirano K Hidetoshi S Okuda M Fujishima Prevention of ACEI-induced worsening of anemia with a concomitant use of erythropoietin in hemodialysis patients J Am Soc Nephrol 5 1994 460 (abstr)
22. AW Yu AYM Wang CTY Tse LM Lu PKT Li SF Lui Both angiotensin II AT1 receptor antagonist and angiotensin-converting enzyme inhibitor do not worsen anemia in CAPD patients J Am Soc Nephrol 9 1998 292A (abstr)
23. JL Truel GF Juarez R Marcen J Nogueira J Ortuno Effect of angiotensin-converting enzyme inhibitors on anemia in hemodialyzed patients Nephron 73 1996 113 (letter)
24. M Matsumara H Nomura I Koni H Mabuchi Angiotensin-converting enzyme inhibitors are associated with the need for increased recombinant human erythropoietin maintenance doses in hemodialysed patients Nephron 77 1997 164 168
25. AW Dhondt RC Vanholder SMG Ringoir Angiotensin-converting enzyme inhibitors and higher erythropoietin requirement in chronic haemodialysis patients Nephrol Dial Transplant 10 1995 2107 2109
26. J Walter Does captopril decrease the effect of human recombinant erythropoietin in haemodialysis patients? Nephrol Dial Transplant 8 1993 1428 (letter)
27. S Erturk K Ates N Duman O Karatan B Erbay E Ertug Unresponsiveness to recombinant human erythropoietin in haemodialysis patients: Possible implications of angiotensin-converting enzyme inhibitors Nephrol Dial Transplant 11 1996 396 397
28. E Heβ M Rajtar S Sonkodi Do ACE inhibitors influence the dose of human recombinant erythropoietin in dialysis patients? Nephrol Dial Transplant 11 1996 749 751
29. JF Navarro ML Macia C Mora-Fernandez E Gallego J Chahin ML Mendez N del Castillo A Rivero J Garcia Effects of angiotensin-converting enzyme inhibitors on anemia and erythropoietin requirements in peritoneal dialysis patients Adv Perit Dial 13 1997 257 259
30. S Albitar R Genin M Fen-Chong MO Serveaux B Bourgeon High-dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients Nephrol Dial Transplant 13 1998 1206 1210
31. D Ducloux Y Sainthillier JM Chalopin Effect of losartan on haemoglobin concentration in renal transplant recipients Nephrol Dial Transplant 12 1997 2683 2686
32. BA Julian RR Brantley CV Barker T Stopka RS Gaston JJ Curtis JY Lee JT Prchal Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in post-transplant erythrocytosis J Am Soc Nephrol 9 1998 1104 1108
33. BA Julian RS Gaston CV Barker G Krystal AG Diethelm JJ Curtis Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis Kidney Int 46 1994 1397 1403
34. J Gossmann P Thurmann T Bachmann S Weller HG Kachel W Schoeppe EH Scheuermann Mechanism of angiotensin-converting enzyme inhibitor-related anemia in renal transplant recipients Kidney Int 50 1996 973 978
35. F Fyhrquist K Karppinen T Honkanen O Saijonmaa K Rosenlof High serum erythropoietin levels are normalized during treatment of congestive heart failure with enalapril J Int Med 226 1989 257 260
36. MC Pratt NJ Lewis-Barned RJ Walker RR Bailey BI Shand J Livesey Effect of angiotensin-converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers Br J Clin Pharmacol 34 1992 363 365
37. A Penhoat P Leduque C Jaillard PG Chatelain PM Dubois JM Saez ACTH and angiotensin II regulation of insulin-like growth factor-1 and its binding proteins in cultured bovine adrenal cells J Mol Endocrinol 7 1991 223 232
38. AG Brox J Mangel JA Hanley G St Louis S Mongrain RF Gagnon Erythrocytosis after renal transplantation represents an abnormality of insulin-like growth factor-1 and its binding proteins Transplantation 66 1998 1053 1058
39. AG Brox F Zhang H Guyda RF Gagnon Subtherapeutic erythropoietin and insulin-like growth factor-1 correct the anemia of chronic renal failure in the mouse Kidney Int 50 1996 937 943